Showing results (641-650 of 690) with videos related to
Sort By:
Pageof 69
Journal of Internal Medicine|February 27, 2023
HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseasesMarthe Kirkesaether Brun, Kristin Hammersbøen Bjørlykke, Marte K Viken, et al.Annals of the Rheumatic Diseases|May 5, 2010
The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritisDiane van der Woude, Silje W Syversen, Ellen I H van der Voort, et al.Vaccines|July 30, 2020
Alterations in the Human Plasma Lipidome in Response to Tularemia VaccinationKristal M Maner-Smith, Johannes B Goll, Manoj Khadka, et al.Nature Communications|June 6, 2024
Global critical soil moisture thresholds of plant water stressZheng Fu, Philippe Ciais, Jean-Pierre Wigneron, et al.Nature Communications|May 27, 2021
Spatially explicit analysis identifies significant potential for bioenergy with carbon capture and storage in ChinaXiaofan Xing, Rong Wang, Nico Bauer, et al.BMC Medicine|October 5, 2022
The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort studyIngrid Egeland Christensen, Ingrid Jyssum, Anne Therese Tveter, et al.Scandinavian Journal of Gastroenterology|February 15, 2023
Humoral immune response to SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive medication: association to serum drug levels and disease typeKristin Kaasen Jørgensen, Marte Lie Høivik, Adity Chopra, et al.Vaccine|July 29, 2017
Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical TrialMark J Mulligan, Jack T Stapleton, Wendy A Keitel, et al.European Heart Journal|August 18, 2021
Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopeniaSverre Holm, Hassen Kared, Annika E Michelsen, et al.RMD Open|November 3, 2022
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapySilje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, et al.Pageof 69